We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$277B
AUM Growth
+$17B
Cap. Flow
+$10.3B
Cap. Flow %
3.74%
Top 10 Hldgs %
13%
Holding
7,048
New
169
Increased
3,077
Reduced
2,915
Closed
401

Sector Composition

Rank Sector Weight
1 Healthcare 8.93%
2 Technology 8.69%
3 Financials 8.37%
4 Communication Services 6.94%
5 Consumer Staples 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
6301
Ascendis Pharma A/S
ASND
$16.1B
-25,759
Closed -$478K
ATOS icon
6302
Atossa Therapeutics
ATOS
$21.3M
0
AUBN icon
6303
Auburn National Bancorp
AUBN
$91.1M
-5
Closed
AVNW icon
6304
Aviat Networks
AVNW
$266M
$0 ﹤0.01%
96
-5
-5% -$19
AVTX icon
6305
Avalo Therapeutics
AVTX
$990M
0
AWRE icon
6306
Aware
AWRE
$25.8M
-400
Closed -$1K
AXR icon
6307
AMREP Corp
AXR
$124M
$0 ﹤0.01%
+27
New +$120
BDRX
6308
Biodexa Pharmaceuticals
BDRX
$1.27M
0
BELFA icon
6309
Bel Fuse Inc Class A
BELFA
$3.24B
-3
Closed
BLFS icon
6310
BioLife Solutions
BLFS
$1.54B
-18
Closed
BLIN icon
6311
Bridgeline Digital
BLIN
$14.6M
0
BNTC icon
6312
Benitec Biopharma
BNTC
$408M
0
BOSC icon
6313
Better Online Solutions
BOSC
$31.7M
-5
Closed
BOTJ icon
6314
Bank Of The James
BOTJ
$123M
-7
Closed
BRT
6315
BRT Apartments
BRT
$276M
$0 ﹤0.01%
+4
New +$29
BTAL icon
6316
AGF US Market Neutral Anti-Beta Fund
BTAL
$305M
-1,000
Closed -$22K
BXC icon
6317
BlueLinx
BXC
$416M
$0 ﹤0.01%
5
CAAS icon
6318
China Automotive Systems
CAAS
$135M
-15,672
Closed -$73K
CCLD icon
6319
CareCloud
CCLD
$104M
-16
Closed
CCM
6320
Concord Medical Services
CCM
$19.2M
-120
Closed -$6K
CENN icon
6321
Cenntro
CENN
$8.11M
0
CETX icon
6322
Cemtrex
CETX
$4.2M
0
CFBK icon
6323
CF Bankshares
CFBK
$234M
-4
Closed
CHCI icon
6324
Comstock Holding Companies
CHCI
$150M
-5
Closed
MBAI
6325
Check-Cap
MBAI
$8.19M
0

Similar funds

Morgan Stanley's Q2 2016 Portfolio in Review

As of Q2 2016, Morgan Stanley held 7,048 positions worth $277B, up 6.5% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Morgan Stanley deployed $10.3B of net new capital in Q2 2016, opening 169 new positions and adding to 3,077 existing holdings. Its largest new stake was S&P Global: 9,342,671 shares worth $1B.

By sector, the portfolio is most concentrated in Healthcare at 8.9% of assets, down from 9.1% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $542M trimmed.

  • Morgan Stanley's largest Q2 2016 buy was S&P Global: 9,342,671 shares worth $1B.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $1.11B increase.
  • Morgan Stanley's biggest Q2 2016 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $542M.
  • Morgan Stanley fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $807M.
  • Morgan Stanley's ten largest holdings make up 13% of its $277B portfolio in Q2 2016.
  • Morgan Stanley opened 169 new positions and closed 401 in Q2 2016.
  • Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $277B.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.